Reuters logo
7 months ago
BRIEF-Sirona Biochem says Wanbang Biopharma will formulate product in Jan 2017 to prepare for clinical trial
December 8, 2016 / 1:29 PM / 7 months ago

BRIEF-Sirona Biochem says Wanbang Biopharma will formulate product in Jan 2017 to prepare for clinical trial

1 Min Read

Dec 8 (Reuters) - Sirona Biochem Corp :

* Sirona Biochem Corp - "expect to receive one or more term sheets from interested parties before end of Q4 2016" for licensing agreement for TFC-1067

* Sirona Biochem Corp - Wanbang Biopharmaceuticals will formulate product (SGLT2 inhibitor) in January 2017 to prepare for a clinical trial

* Sirona Biochem - Wanbang Biopharma will conduct additional pharmacology, toxicology study and file IND package with Chinese FDA for SGLT2 inhibitor

* Sirona Biochem Corp - Valeant is aware of delays in scale-up and has not altered plans to commercialize skin lightener, TFC-849 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below